Recovery from anthracycline cardiomyopathy--how can it be explained?
Christiansen
Stefan
S
D000293:Adolescent; D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy*; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005355:Fibrosis; D006353:Heart-Assist Devices; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009206:Myocardium / Q000473:pathology
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin